Ensign Group Q3 2026 earnings

ENSG · 2026-10-27 16:11 AMC ET · 8-K on SEC

Revenue and adjusted earnings per share increased 14.5% and 23.8% respectively, with occupancy and skilled mix also rising year-over-year.

Headline numbers

MetricActualYoYQoQ8-K location
Revenue$1.48B+14.5%—Ex. 99.1, income statement
EPS (GAAP)$1.76+23.9%—Ex. 99.1, income statement
EPS (adjusted)$2.03+23.8%—Ex. 99.1, income statement
Net income$104.3M+24.4%—Ex. 99.1, income statement
Adj. EBITDA$190.7M+25.8%—Ex. 99.1, income statement
Adj. EBITDA margin12.9%+1.2 pp—Ex. 99.1, income statement

Revenue breakdown

SegmentActualYoYShare of revenueNote
Skilled ServicesNot disclosed+14.5%—Revenue increased 14.5% YoY; Same Facilities skilled mix revenue increased 10.7% YoY
Standard Bearer$47.7M+46.3%3.2%Includes rental revenue of $47.7M, of which $42.1M from Ensign-affiliated operations

Margins and costs

  • Gross margin Not disclosed
  • Operating expenses $1.35B (+12.8% YoY)
  • One-offs in the quarter Litigation: $12.0M (Q3 2025); Gain on other investments: $2.4M (Q3 2025); Write off deferred financing fees: $0.2M (Q3 2026); Depreciation and amortization - patient base: $1.0M (Q3 2025)
  • Effective tax rate 25.0% (prior-year 21.3%, year-to-date 24.5%)
  • Non-GAAP bridge Adds back stock-based compensation ($19.0M), acquisition related costs ($0.2M), system implementation costs ($1.7M), litigation ($12.0M Q3 2025), and gains on investments ($2.4M Q3 2025).

KPIs

MetricActualPrior quarterPrior yearChange
Same Facilities occupancy84.1%—+1.6 pp—
Transitioning Facilities occupancy86.1%—+3.9 pp—
FFO$27.3M—+41.3%—

Guidance

MetricGuidePrior guideChange
2026 EPS$7.94 - $8.02$7.75 - $7.85+0.19 - +0.17
2026 Revenue$5.89B - $5.92B$5.89B - $5.92BMaintained

What drove it

  • Revenue story Consolidated revenue increased 14.5% YoY driven by growth across all skilled payor categories; Same Facilities skilled mix revenue increased 10.7% YoY and Medicare revenue increased 11.1% YoY.
  • EPS story EPS increased 23.8% YoY driven by revenue growth, improved margins, and a lower tax rate.
  • One-off check Litigation expense of $12.0M in Q3 2025 and a gain on other investments of $2.4M in Q3 2025 were non-recurring items.

The good

  • Adjusted EPS increased 23.8% YoY to $2.03
  • FFO increased 41.3% YoY to $27.3M
  • Same Facilities occupancy increased 1.6 pp YoY to 84.1%
  • Standard Bearer revenue increased 46.3% YoY to $47.7M

The bad

  • none

The ugly

  • none

Open questions

  • What was the prior quarter's revenue and EPS?
  • What was the prior quarter's occupancy and skilled mix?
  • What was the prior quarter's FFO?
  • What was the prior quarter's Adj. EBITDA margin?
Full release

Earnings: ENSG — filed 2026-10-27

ENSIGN GROUP, INC (ENSG) · Form 8-K, Item 2.02 · Filed · SEC filing

The Ensign Group Reports Third Quarter 2026 Results;

Raises 2026 Annual Earnings Guidance

Conference Call and Webcast scheduled for tomorrow, October 28, 2026 at 10:00 am PT

SAN JUAN CAPISTRANO, California – October 27, 2026 – The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign

(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, primarily in skilled nursing and senior living facilities, announced operating results for the third quarter ended September 30, 2026, reporting GAAP diluted earnings per share of $1.76 and adjusted earnings per share

Financial statements

Income Statement

Three Months Ended September 30, — UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
REVENUEService revenue1,476,8351,289,7794,291,6353,678,233
REVENUERental revenue7,1676,62622,04418,982
REVENUETOTAL REVENUE1,484,0021,296,4054,313,6793,697,215
Expense:Cost of services1,166,8021,044,6593,396,8652,944,288
Expense:Rent—cost of services66,97061,528198,888175,799
Expense:General and administrative expense79,59567,367239,727199,029
Expense:Depreciation and amortization32,64626,63392,85376,606
Expense:TOTAL EXPENSES1,346,0131,200,1873,928,3333,395,722
Expense:Income from operations137,98996,218385,346301,493
Other income (expense):Interest expense-2,286-1,971-6,151-6,033
Other income (expense):Interest income4,7176,16815,88618,291
Other income (expense):Other (expense) income-2226,1857,36311,787
Other income (expense):OTHER INCOME, NET2,20910,38217,09824,045
Other income (expense):Income before provision for income taxes140,198106,600402,444325,538
Other income (expense):Provision for income taxes35,81422,68998,47076,808
Other income (expense):NET INCOME104,38483,911303,974248,730
Other income (expense):Less: net income attributable to noncontrolling interests12267306213
Other income (expense):NET INCOME ATTRIBUTABLE TO THE ENSIGN GROUP, INC.104,26283,844303,668248,517
NET INCOME PER SHARE ATTRIBUTABLE TO THE ENSIGN GROUP INC.Basic1.81.465.254.34
NET INCOME PER SHARE ATTRIBUTABLE TO THE ENSIGN GROUP INC.Diluted1.761.425.114.23
WEIGHTED AVERAGE COMMON SHARES OUTSTANDINGBasic57,82457,38257,85157,214
WEIGHTED AVERAGE COMMON SHARES OUTSTANDINGDiluted59,30358,95659,45558,713

Income Statement

Three Months Ended September 30, — The following table reconciles net income to Adjusted net income and diluted earnings per share to Adjusted earnings per share for the periods presented:

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Net income attributable to The Ensign Group, Inc.104,26283,844303,668248,517
Adjustments:Stock-based compensation expense(1)19,04412,98949,10535,375
Adjustments:Cost of services - Litigation(2)12,00012,000
Adjustments:Cost of services - acquisition related costs(3)2135281,0131,663
Adjustments:Cost of services - (gain) loss on long-lived assets and business interruption recoveries, net-564-1,660720-2,660
Adjustments:General and administrative - costs incurred related to system implementations1,7217016,9201,472
Adjustments:Depreciation and amortization - patient base(4)1,020
Adjustments:Interest expense - write off deferred financing fees(5)159159
Adjustments:Other income - gain on other investments (6)-2,437-2,437
Adjustments:Provision for income taxes on Non-GAAP adjustments(7)-4,379-9,491-16,621-16,184
Adjustments:Adjusted Net Income120,45696,474344,964278,766
Adjustments:Average number of diluted shares outstanding59,30358,95659,45558,713
Adjustments:Diluted Earnings Per Share1.761.425.114.23
Adjustments:Adjusted Earnings Per Share2.031.645.84.75
(1) Represents stock-based compensation expense incurred.Cost of services12,8148,68732,70723,720
(1) Represents stock-based compensation expense incurred.General and administrative6,2304,30216,39811,655
(1) Represents stock-based compensation expense incurred.Total Non-GAAP adjustment19,04412,98949,10535,375
(1) Represents stock-based compensation expense incurred.(2) Represents specific proceedings and adjustments arising outside of the ordinary course of business.(2) Represents specific proceedings and adjustments arising outside of the ordinary course of business.
(1) Represents stock-based compensation expense incurred.(3) Represents costs incurred to acquire operations that are not capitalizable.(3) Represents costs incurred to acquire operations that are not capitalizable.
(1) Represents stock-based compensation expense incurred.(4) Represents amortization expenses related to patient base intangible assets at newly acquired skilled nursing and senior living facilities.(4) Represents amortization expenses related to patient base intangible assets at newly acquired skilled nursing and senior living facilities.
(1) Represents stock-based compensation expense incurred.(5) Represents the write off of deferred financing fees associated with the Credit Facility.(5) Represents the write off of deferred financing fees associated with the Credit Facility.
(1) Represents stock-based compensation expense incurred.(6) Represents gains on the sale of investments that are not part of our core business operations. These investments have no observable market prices and are held at historical cost basis until sold or impaired.(6) Represents gains on the sale of investments that are not part of our core business operations. These investments have no observable market prices and are held at historical cost basis until sold or impaired.

Income Statement

Three Months Ended September 30, — The table below reconciles net income to EBITDA, Adjusted EBITDA and Adjusted EBITDAR for the periods presented:

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Consolidated Statements of Income Data:Net income104,38483,911303,974248,730
Consolidated Statements of Income Data:Less: Net income attributable to noncontrolling interests12267306213
Consolidated Statements of Income Data:Interest income4,7176,16815,88618,291
Consolidated Statements of Income Data:Add: Provision for income taxes35,81422,68998,47076,808
Consolidated Statements of Income Data:Depreciation and amortization32,64626,63392,85376,606
Consolidated Statements of Income Data:Interest expense2,2861,9716,1516,033
Consolidated Statements of Income Data:EBITDA170,291128,969485,256389,673
Adjustments to EBITDA:Stock-based compensation expense19,04412,98949,10535,375
Adjustments to EBITDA:Costs incurred related to system implementations1,7217016,9201,472
Adjustments to EBITDA:Acquisition related costs(1)2135281,0131,663
Adjustments to EBITDA:(Gain) loss on long-lived assets and business interruption recoveries, net-564-1,660720-2,660
Adjustments to EBITDA:Litigation(2)12,00012,000
Adjustments to EBITDA:Gain on other investments(3)-2,437-2,437
Adjustments to EBITDA:ADJUSTED EBITDA190,705151,090543,014435,086
Adjustments to EBITDA:Rent—cost of services66,97061,528198,888175,799
Adjustments to EBITDA:ADJUSTED EBITDAR257,675741,902

Income Statement

Three Months Ended September 30, — The table below reconciles income before provision for income taxes to Adjusted EBT for the periods presented: (in thousands)

Three Months Ended September 30, – 2026Three Months Ended September 30, – 2025Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
Income before provision for income taxes140,198106,600402,444325,538
Stock-based compensation expense19,04412,98949,10535,375
Costs incurred related to system implementations1,7217016,9201,472
Acquisition related costs(1)2135281,0131,663
(Gain) loss on long-lived assets and business interruption recoveries, net-564-1,660720-2,660
Litigation(2)12,00012,000
Gain on other investments(3)-2,437-2,437
Write off deferred financing fees(4)159159
Depreciation and amortization - patient base(5)1,020
ADJUSTED EBT160,771128,721460,361371,971

Balance Sheet

September 30, 2026 — (In thousands) (in thousands)

September 30, 2026December 31, 2025
Current assets:Cash and cash equivalents337,592503,881
Current assets:Accounts receivable—less allowance for doubtful accounts of $7,910 and $7,805 at September 30, 2026 and December 31, 2025, respectively664,773636,985
Current assets:Investments—current54,10268,506
Current assets:Prepaid expenses and other current assets98,41662,932
Current assets:Total current assets1,154,8831,272,304
Current assets:Property and equipment, net2,278,2311,696,863
Current assets:Right-of-use assets2,117,4572,097,862
Current assets:Insurance subsidiary deposits and investments219,988166,841
Current assets:Deferred tax assets83,18883,138
Current assets:Restricted and other assets40,45941,600
Current assets:Intangible assets, net6,2036,381
Current assets:Goodwill97,98197,981
Current assets:TOTAL ASSETS5,998,3905,462,970
Current liabilities:Accounts payable125,37497,327
Current liabilities:Accrued wages and related liabilities420,724422,326
Current liabilities:Lease liabilities—current120,388114,816
Current liabilities:Accrued self-insurance liabilities—current111,02181,623
Current liabilities:Other accrued liabilities181,365174,027
Current liabilities:Current maturities of long-term debt4,0404,227
Current liabilities:Total current liabilities962,912894,346
Current liabilities:Long-term lease liabilities—less current portion1,968,5391,949,213
Current liabilities:Accrued self-insurance liabilities—less current portion201,675164,792
Current liabilities:Other long-term liabilities107,18982,266
Current liabilities:Long-term debt—less current maturities194,684137,529
Current liabilities:Total equity2,563,3912,234,824
Current liabilities:TOTAL LIABILITIES AND EQUITY5,998,3905,462,970

Cash Flow

Nine Months Ended September 30, — The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:

Nine Months Ended September 30, – 2026Nine Months Ended September 30, – 2025
NET CASH PROVIDED BY (USED IN):Operating activities512,348380,950
NET CASH PROVIDED BY (USED IN):Investing activities-690,937-389,237
NET CASH PROVIDED BY (USED IN):Financing activities12,300-12,643
NET CASH PROVIDED BY (USED IN):Net decrease in cash and cash equivalents-166,289-20,930
NET CASH PROVIDED BY (USED IN):Cash and cash equivalents beginning of period503,881464,598
NET CASH PROVIDED BY (USED IN):Cash and cash equivalents at end of period337,592443,668

(2) of $2.03.

"We are thrilled to report another outstanding quarter. Our teams continue to demonstrate their unwavering commitment to dignifying post-acute care through moments of truth. Our core values, which our teams refer to using the acronym CAPLICO, create a shared culture that empowers nearly 60,000 partners to lead with compassion, accountability, ownership, and a relentless commitment to excellence. We believe culture is not separate from performance, it is the foundation that makes sustainable clinical, operational and financial performance possible,” said Barry Port, Chief Executive Officer of The Ensign Group.

"Our clinical leaders also continue to drive outstanding outcomes, which is particularly impressive given our growth over the past several years. According to the most recently published CMS data, our Same Facilities achieved annual survey results that were 15% better at the state level and 28% better at the county level. This is especially notable given that many of these facilities were 1- and 2-star buildings at acquisition. Additionally, our Same Facilities outperformed in 5-Star Quality Measure results by 21% at the state level. These results reinforce our position as the provider of choice in our markets and demonstrate our ability to create long-term value through sustained clinical excellence,” Port said.

Clinical Highlights

(1)

:

▪ Same Facilities achieved Centers for Medicare & Medicaid Services (CMS) Quality Measure ratings that were 21% better than industry peers in our operating states, demonstrating superior clinical outcomes.

▪ Same Facilities achieved CMS Cycle 1 survey inspection results that were 15% better than industry peers in our operating states, validating clinical excellence through regulatory oversight.

▪ Over 80% of our skilled nursing operations earned a CMS Quality Measure rating of 4 or 5 stars, demonstrating our continued commitment to delivering high-quality clinical care.

▪ Short-stay residents achieved functional improvement rates 30% better than industry peers in our operating states, reflecting our focus on rehabilitation and helping patients regain independence.

▪ Long-stay residents had antipsychotic medication rates 28% better than industry peers in our operating states, reflecting our focus on appropriate medication management and resident-centered care.

▪ Administrator turnover for Same Facilities was 45% lower than our industry peers in our operating states, supporting leadership continuity and operational stability.

▪ 12% of all our eligible operations, comprised of 40 buildings in 8 different states, earned CMS High Performing designations under its new risk-based survey program, placing them among a select group of facilities recognized by CMS for consistently strong performance.

▪ 43 Ensign-affiliated operations were recognized on Newsweek’s America’s Best Nursing Homes 2027 list.

Financial Highlights:

▪ GAAP diluted earnings per share for the quarter was $1.76, an increase of 23.9% over the prior year quarter, and adjusted diluted earnings per share

(2) for the quarter was $2.03, an increase of 23.8% over the prior year quarter.

▪ GAAP net income was $104.3 million for the quarter, an increase of 24.4% over the prior year quarter, and adjusted net income

(2) was $120.5 million for the quarter, an increase of 24.9% over the prior year quarter.

▪ Same Facilities and Transitioning Facilities occupancy for the quarter were 84.1% and 86.1%, an increase of 1.6% and 3.9%, respectively, over the prior year quarter.

▪ Same Facilities and Transitioning Facilities skilled mix revenue for the quarter increased by 10.7% and 10.5%, respectively, over the prior year quarter and skilled days for the quarter increased by 7.2% and 7.9%, respectively, over the prior year quarter.

▪ Same Facilities and Transitioning Facilities Medicare revenue for the quarter improved by 11.1% and 7.8%, respectively, from the prior year quarter and Medicare days for the quarter improved by 7.6% and 6.3%, respectively, from the prior year quarter.

▪ Same Facilities and Transitioning Facilities managed care revenue for the quarter improved by 9.1% and 7.2%, respectively, from the prior year quarter and managed care days for the quarter improved by 3.1% and 3.8%, respectively, from the prior year quarter.

▪ Consolidated revenue for the quarter was $1.48 billion, an increase of 14.5% over the prior year quarter.

▪ Standard Bearer

(3) revenue was $47.7 million for the quarter, an increase of 46.3% over the prior year quarter. FFO was $27.3 million for the quarter, an increase of 41.3% over the prior year quarter.

(1)

The data source for clinical results is from CMS Care Compare Five-Star Quality Rating System, September 2026. Cycle 1 survey inspection results are based on the latest CMS-reported regulatory inspection cycle which reflects results as of Q1 2026. State-wide averages represent the average reported performance of facilities within the states in which we operate. National averages represent the average performance of all facilities included in the CMS Care Compare database nationwide.

(2)

See "Reconciliation of GAAP to Non-GAAP Financial Information".

(3)

Our Skilled Services and Standard Bearer Segments are defined and outlined in Note 7 on Form 10-Q.

Clinical and Operating Results... (truncated)d across our portfolio and experienced growth in occupancy and skilled mix during the quarter. In particular, we saw year-over-year growth across all skilled payor categories during the quarter, with growth in Medicare being particularly strong. On the census front, our Same Facilities and Transitioning occupancy for the third quarter was 84.1% and 86.1%, respectively. In addition to growing census, our Same Facilities and Transitioning Facilities skilled mix revenue increased by 10.7% and 10.5%, respectively, over the prior year quarter. Medicare revenue increased for both our Same Facilities and Transitioning Facilities by 11.1% and 7.8%, respectively. Also, managed care revenue increased by 9.1% and 7.2%, respectively, for Same Facilities and Transitioning Facilities over the prior year quarter, with total skilled days up 7.2% and 7.9%, respectively, from the prior year quarter,” Port said.

He added, “These improvements in occupancy and skilled mix clearly demonstrate that patients, families, hospital systems, physicians, and managed care organizations continue to choose Ensign affiliated operations because of the outcomes our teams achieve and the distinctive culture and experience our local teams create every day. This cannot and will not happen, especially consistently and over a long period of time, without consistently achieving these industry-leading high-quality clinical outcomes. Occupancy and skilled mix are more than financial metrics; they are one of the clearest external validations that an operation consistently delivers the outcomes and experience that stakeholders value."

“Due to the strength of the third quarter and our confidence in the fourth quarter, we are increasing our annual 2026 earnings guidance to $7.94 to $8.02 per diluted share, up from our original guidance of $7.75 to $7.85. We are also raising the lower end of our annual revenue guidance to $5.89 billion, while maintaining the upper end at $5.92 billion. The midpoint of our earnings guidance represents a 21.5% increase over 2025 and 45.5% growth over 2024," Mr. Port said.

Speaking to the Company’s acquisition growth, Chad Keetch, Ensign’s Chief Investment Officer and Executive Vice President said, “We continue to acquire new operations with significant long-term upside and expect to maintain a healthy pace of growth as we expand our mission driven approach to transform and dignify post-acute care. During the quarter and since, we accelerated our growth by adding 22 new operations, including three real estate assets and 19 leased operations. We also acquired five real estate properties that were under lease arrangements that we are operating. Since 2024, we have successfully sourced, underwritten, closed, and transitioned 122 new operations across several markets, many of which are already performing at or above expectations, both clinically and financially. We continue to see opportunities that include everything from larger portfolios, landlords looking to replace current tenants, non-profits looking to divest of their post-acute assets and a steady flow of traditional one offs. We have several new additions lining up for next year as our local leadership and their partners at the Service Center work together to source, underwrite and carefully select the right opportunities.”

Suzanne Snapper, Ensign’s Executive Vice President and Chief Financial Officer reported that the Company’s liquidity remains strong with approximately $337.6 million of cash on hand and $731.6 million of available capacity under its line-of-credit. Ms. Snapper also indicated that, “Management’s annual guidance is based on diluted weighted average common shares outstanding of approximately 59.5 million and a 25.0% tax rate. In addition, the guidance assumes, among other things, normalized insurance costs, acquisitions expected to close through the fourth quarter of 2026 and management’s current expectations regarding reimbursement rates. It also excludes certain charges that arise outside the normal course of business, amortization of system implementation costs, acquisition related costs and share-based compensation.”

A discussion of the Company's use of non-GAAP financial measures is set forth below. A reconciliation of net income to adjusted EBT, EBITDA, adjusted EBITDAR, adjusted EBITDA and FFO for Standard Bearer, as well as a reconciliation of GAAP earnings per share, net income to adjusted net income and adjusted net earnings per share appear in the financial data portion of this release. More complete information is contained in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, which is expected to be filed with the SEC today and can be viewed on the Company’s website at http://www.ensigngroup.net.

Growth and Real Estate Highlights

Mr. Keetch added additional commentary on the Company’s continued acquisition activity. “We were thrilled to complete these acquisitions and to expand our presence in several key markets, including our entrance into Florida. Florida represents a natural continuation of our strategic expansion into the Southeast, which began with our entry into Tennessee, South Carolina and Alabama. Our approach has been deliberate: enter new markets, develop strong local leadership and clusters, and build the infrastructure necessary to support disciplined growth over time," Mr. Keetch said.

The recent acquisitions include the following leased operations:

• Delta Post Acute and Rehabilitation, an 80-bed skilled nursing facility located in Delta, CO;

• La Villa Grande Care Center, a 96-bed skilled nursing facility located in Grand Junction, CO;

• Milestone Health and Rehabilitation, a 190-bed skilled nursing facility located in Littleton, CO;

• Monument Ridge Health and Rehabilitation, an 88-bed skilled nursing facility located in Grand Junction, CO;

• Pendant Health and Rehabilitation, a 130-bed skilled nursing facility located in Lakewood, CO;

• ... (truncated)bilitation, a healthcare campus with 85 skilled nursing beds and 47 independent living units located in Canon City, CO;

• Spring Village Care Center, a 91-bed skilled nursing facility located in Colorado Springs, CO;

• Burien Nursing and Rehabilitation, a 140-bed skilled nursing facility located in Burien, WA;

• Issaquah Nursing and Rehabilitation, a 140-bed skilled nursing facility located in Issaquah, WA;

• Park Ridge Nursing and Rehabilitation, a 115-bed skilled nursing facility located in Shoreline, WA;

• Park West Nursing and Rehabilitation, a 137-bed skilled nursing facility located in Seattle, WA;

• Bay Park Post-Acute and Rehabilitation, a 101-bed skilled nursing facility located in Sarasota, FL;

• Carrabelle Post-Acute and Rehabilitation, a 90-bed skilled nursing facility located in Carrabelle, FL;

• Cedar Hill Post-Acute and Rehabilitation, a 120-bed skilled nursing facility located in Jacksonville, FL;

• Davenport Post-Acute and Rehabilitation, a healthcare campus with 60 skilled nursing beds and 66 independent living units located in Davenport, FL;

• Greenville Post-Acute and Rehabilitation, a 58-bed skilled nursing facility located in Greenville, FL;

• Lake Haven Post-Acute and Rehabilitation, a 104-bed skilled nursing facility located in Dunedin, FL;

• Monticello Post-Acute and Rehabilitation, a 60-bed skilled nursing facility located in Monticello, FL; and

• Shores Post-Acute and Rehabilitation, a 120-bed skilled nursing facility located in Port Saint Joe, FL.

Standard Bearer announced the following real estate acquisitions, which are operated by an Ensign-affiliate:

• Las Ventanas de Socorro, a 126-bed skilled nursing facility located in Socorro, Texas;

• Los Arcos del Norte Care Center, a 124-bed skilled nursing facility located in El Paso, Texas; and

• Englewood Heights Nursing and Rehabilitation, a 118-bed skilled nursing facility located in Pensacola, Florida.

Additionally, Standard Bearer announced it acquired the real estate assets of five facilities that were previously operated under third-party triple net leases. These facilities total 755 skilled nursing beds and are now subject to long-term leases with subsidiaries of Standard Bearer.

Ensign's growing portfolio consists of 418 healthcare operations, 34 of which also include senior living operations, across 18 states. Ensign now owns 189 real estate assets, 150 of which are operated by an Ensign affiliate. Mr. Keetch noted that Ensign’s overall strategy will continue to include both leasing and acquiring the real estate, and that the Company is actively looking for performing and underperforming operations in several states.

The Company continues to provide additional disclosure on Standard Bearer, which is comprised of 183 owned properties. Of these assets, 146 are leased to Ensign-affiliated operators and 38 are leased to third-party operators. Mr. Keetch noted that each of these properties are subject to triple-net, long-term leases and generated rental revenue of $47.7 million for the quarter, of which $42.1 million was derived from Ensign affiliated operations. For the quarter, Ensign reported $27.3 million in FFO.

The Company also paid a quarterly cash dividend of $0.065 per share of Ensign common stock. Ms. Snapper noted that as the Company’s liquidity remains strong, it plans to continue its long history of paying dividends into the future.

Conference Call

A live webcast will be held on Wednesday, October 28, 2026, at 10:00 a.m. Pacific time (1:00 p.m. Eastern time) to discuss Ensign’s third quarter of 2026 financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors Relations section of Ensign’s website at http://investor.ensigngroup.net. The webcast will be recorded and will be available for replay via the website until 5:00 p.m. Pacific time on Friday, November 27, 2026.

About Ensign™

The Ensign Group, Inc.'s independent subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 418 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Florida, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. As part of its investment strategy, the Company will also acquire, lease and own healthcare real estate to service the post-acute care continuum through acquisition and investment opportunities in healthcare properties. Ensign’s new business venture operating subsidiaries also offer several other post-acute-related services, including mobile x-ray, emergency and non-emergency transportation services, long-term care pharmacy and other consulting services also across several states. Each of these operations is operated by a separate, independent subsidiary that has its own management, employees and assets. References herein to the consolidated "Company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Ensign Group, Inc. has direct operating assets, employees or revenue, or that any of the facilities, the Service Center, Standard Bearer or the captive insurance subsidiary are operated by the same entity. More information about Ensign is available at http://www.ensigngroup.net.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:... (truncated)ll," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the Company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Additionally, our business and operations continue to be impacted by the unprecedented nature of the changes in the regulations and environment, as such, we are unable to predict the full extent and duration of the financial impact of these changes on our business, financial condition and results of operations. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the Company’s periodic filings with the Securities and Exchange Commission, including its Form 10-Q and 10-K, for a more complete discussion of the risks and other factors that could affect Ensign’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Ensign does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Contact Information

Investor/Media Relations, The Ensign Group, Inc., (949) 487-9500, ir@ensignservices.net.

SOURCE: The Ensign Group, Inc.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Ensign Group earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.